E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/29/2016 in the Prospect News PIPE Daily.

AntriaBio sells $12 million of equity units through private placement

Units of shares and either one warrant or one half-share warrant sold

By Devika Patel

Knoxville, Tenn., June 29 – AntriaBio, Inc. settled a $12 million private placement of units. The deal priced for $3.27 million on May 31.

The company sold units of one common share and either one warrant or one half-share warrant at $1.10 per unit. It sold 2,967,935 units in the first tranche.

Investors who invested in one of AntriaBio’s previous private placement transactions and also invested a minimum of $50,000 in this private placement received whole warrants in their units. Other investors received half-share warrants in their units.

Each whole warrant is exercisable at $1.65 for five years. The strike price is a 79.35% premium to the May 27 closing share price of $0.92.

The biopharmaceutical company is based in Louisville, Colo.

Issuer:AntriaBio, Inc.
Issue:Units of one common share and either one warrant or one half-share warrant
Amount:$12 million
Price:$1.10
Warrants:Either one warrant or one half-share warrant per unit
Warrant expiration:Five years
Warrant strike price:$1.65
Settlement dates:May 31 (for $3,264,729), June 29
Stock symbol:OTCBB: ANTB
Stock price:$0.92 at close May 27
Market capitalization:$22.39 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.